Cerity Partners
JAZZ icon

Cerity Partners’s Jazz Pharmaceuticals JAZZ Stock Holding History

Cerity Partners’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.9M Buy
53,534
+7,788
+17% +$1.71M 0.02% 642
2026
Q1 		$8.65M Buy
45,746
+7,058
+18% +$1.23M 0.01% 769
2025
Q4 		$6.58M Buy
38,688
+1,968
+5% +$302K 0.01% 820
2025
Q3 		$4.84M Sell
36,720
-1,246
-3% -$149K 0.01% 867
2025
Q2 		$4.03M Buy
37,966
+17
+0% +$1.85K 0.01% 907
2025
Q1 		$4.71M Buy
37,949
+4,744
+14% +$619K 0.01% 755
2024
Q4 		$3.91M Buy
33,205
+448
+1% +$52.8K 0.01% 820
2024
Q3 		$3.65M Buy
32,757
+18,414
+128% +$2.02M 0.01% 841
2024
Q2 		$1.53M Sell
14,343
-4,164
-22% -$458K ﹤0.01% 1039
2024
Q1 		$2.23M Buy
+18,507
New +$2.27M 0.01% 924
2021
Q1 		– Sell
-2,358
Closed -$389K – 723
2020
Q4 		$389K Buy
+2,358
New +$351K 0.01% 460
2020
Q1 		– Sell
-3,459
Closed -$516K – 488
2019
Q4 		$516K Buy
+3,459
New +$471K 0.03% 330

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Cerity Partners's JAZZ Position: Q2 2026 in Review

Cerity Partners increased its Jazz Pharmaceuticals (JAZZ) stake by 17% in Q2 2026, buying an estimated $1.71M and bringing the position to 53,534 shares worth $12.9M. The position accounts for 0.02% of the portfolio, ranked #642.

Cerity Partners first reported a position in JAZZ in Q4 2019 and has held it in 12 quarters since. 602 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Cerity Partners held 53,534 shares of Jazz Pharmaceuticals worth $12.9M as of Q2 2026.
  • Cerity Partners bought 7,788 Jazz Pharmaceuticals shares in Q2 2026, an estimated $1.71M.
  • Jazz Pharmaceuticals made up 0.02% of Cerity Partners's portfolio in Q2 2026, its #642 holding.
  • Cerity Partners first reported a position in Jazz Pharmaceuticals in Q4 2019 and has held it in 12 quarters since.
  • 602 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.